CD9 and acute myeloid leukemia: Furthermore, Bouvy et al. [36] demonstrated a direct transfer of the multidrug resistance protein 1 (MRP-1) between daunorubicin-resistant AML cells and other leukaemic cells, whereas Hong et al. [68] suggested that AML-derived EVs could confer resistance to adoptive cell therapies.